METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER
Clinical trials for METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Stress-Boosting drug make immunotherapy work for Hard-to-Treat colorectal cancer?
Disease control Recruiting nowThis phase 1 trial tests a new two-drug combination for people with metastatic colorectal cancer that is microsatellite stable (MSS), a type that typically does not respond to immunotherapy alone. The study combines LB-100, which blocks a protein called PP2A to increase stress si…
Matched conditions: METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER
Phase: PHASE1 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New immunotherapy cocktail takes on stubborn colorectal cancer
Disease control Recruiting nowThis early-phase trial is testing whether combining two immunotherapy drugs—nadunolimab and toripalimab—can help people with metastatic colorectal cancer that no longer responds to chemotherapy. The study will enroll 24 participants and first check for safety, then measure how ma…
Matched conditions: METASTATIC MICROSATELLITE-STABLE COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Dan Feng • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC